These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 4937721

  • 1. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method].
    Hirayama K, Uono M, Nakanishi T, Kato N, Nagao Y.
    Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721
    [No Abstract] [Full Text] [Related]

  • 2. 3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
    Muenter MD, Dinapoli RP, Sharpless NS, Tyce GM.
    Mayo Clin Proc; 1973 Mar; 48(3):173-83. PubMed ID: 4570387
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical study of L-dopa in Parkinson's disease].
    Franken L, Noel G, Lhoas JP, Meyers C, Noel P, Ectors M.
    Brux Med; 1972 Dec; 52(12):851-60. PubMed ID: 4575350
    [No Abstract] [Full Text] [Related]

  • 4. [Efficacy and side effects of L-dopa in patients with Parkinson's syndrome].
    Lombardo L.
    Arch Invest Med (Mex); 1973 Dec; 4(3):215-24. PubMed ID: 4784173
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mood changes during l-dopa therapy.
    Anumonye A.
    J Med Soc N J; 1972 Feb; 69(2):139-43. PubMed ID: 4550284
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of Parkinson's disease with levodopa].
    Sigwald J, Raymondeaud C, Grégoire J.
    Therapeutique; 1972 Nov; 48(9):543-54. PubMed ID: 4650524
    [No Abstract] [Full Text] [Related]

  • 10. [Factors which influence infavourably l-dopa treatment].
    Presthus J.
    Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2115-6. PubMed ID: 4590071
    [No Abstract] [Full Text] [Related]

  • 11. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
    Ferel D.
    Schweiz Med Wochenschr; 1972 Jan 22; 102(3):88-94. PubMed ID: 4551909
    [No Abstract] [Full Text] [Related]

  • 12. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 22; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 13. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
    Okajima T, Kubota A, Nakahara N, Takeda S, Shimomura K.
    Naika; 1972 Apr 22; 29(2):335-43. PubMed ID: 4552443
    [No Abstract] [Full Text] [Related]

  • 14. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
    Yahr MD, Duvoisin RC, Hoehn MM, Schear MJ, Barrett RE.
    Trans Am Neurol Assoc; 1968 Apr 22; 93():56-63. PubMed ID: 4885744
    [No Abstract] [Full Text] [Related]

  • 15. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 22; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

  • 16. [Attempt at treating parkinsonism with L-dopa and Artane].
    Stelmasiak Z, Lackowska H, Maksymowicz B.
    Pol Tyg Lek; 1971 Aug 23; 26(34):1325-6. PubMed ID: 5110789
    [No Abstract] [Full Text] [Related]

  • 17. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U.
    Dtsch Med Wochenschr; 1972 Apr 28; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B.
    Rev Neurol (Paris); 1970 Feb 28; 122(2):89-102. PubMed ID: 4931719
    [No Abstract] [Full Text] [Related]

  • 19. [L-dopa and Parkinson's disease].
    Barbeau A.
    Union Med Can; 1970 Dec 28; 99(12):2195-7. PubMed ID: 5488646
    [No Abstract] [Full Text] [Related]

  • 20. Psychiatric changes in patients treated with levodopa. I. The clinical experiment.
    Knopp W.
    Neurology; 1970 Dec 28; 20(12):23-30. PubMed ID: 4924341
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.